Clonal Pre-amplification in Emulsion for Bias-Free Nucleic Acid Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid amplification methods face challenges in efficiently amplifying small amounts of nucleic acid from single or few cells without distorting information content, particularly due to biases, errors, and limitations in PCR technology, such as preferential amplification of shorter fragments and GC-rich sequences, leading to differential representation of DNA populations.

Innovation Solution

A method involving clonal pre-amplification of nucleic acid molecules by attaching adaptor sequences to their ends, preparing a water-in-oil emulsion where each droplet contains one or none of the molecules, and performing PCR within these droplets to amplify them, ensuring unbiased amplification and maintaining representation frequencies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional PCR amplification is used to amplify small amounts of nucleic acid, then amplification efficiency is improved, but bias and distortion of information content occur

Engineering Contradiction:
Improveamplification efficiencyVSAvoidinformation content distortion
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The invention segments the amplification process into two distinct phases: clonal pre-amplification in compartmentalized droplets (to generate sufficient material) and subsequent analysis (to preserve information integrity). This segmentation allows efficient amplification without the bias problems of conventional PCR by using isothermal strand-displacement amplification in isolated compartments, then analyzing the amplified products without further biased amplification.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention introduces an intermediary compartmentalization system using water-in-oil emulsion droplets as isolated reaction chambers. Each droplet acts as an independent intermediary environment that contains amplification reagents and template nucleic acids, preventing cross-contamination and bias while enabling efficient clonal amplification through strand-displacement mechanisms without the competitive dynamics of conventional PCR.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If PCR amplification is used to amplify nucleic acid from single or few cells, then sufficient material for analysis is obtained, but preferential amplification of shorter fragments and GC-rich sequences occurs

Engineering Contradiction:
Improveamount of nucleic acidVSAvoidrepresentation accuracy
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The invention changes the fundamental parameters of the amplification reaction by using isothermal conditions (constant temperature) instead of thermal cycling, and strand-displacement amplification instead of competitive PCR. These parameter changes eliminate the preferential amplification of shorter or GC-rich sequences that occurs in conventional PCR, as the isothermal strand-displacement mechanism amplifies all sequences with equal efficiency regardless of length or composition.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention performs preliminary clonal amplification in compartmentalized droplets before final analysis. This preliminary action generates sufficient quantity of nucleic acid material from single or few cells while maintaining accurate representation, because the strand-displacement amplification occurs in isolated compartments without the competitive dynamics that cause bias in conventional PCR.

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If in vitro transcription amplification is used, then RNA samples can be amplified, but the method is time-consuming and produces less stable amplificates

Engineering Contradiction:
ImproveRNA amplification capabilityVSAvoidamplification time
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The invention replaces the multi-step mechanical process of in vitro transcription (cDNA synthesis, RNA synthesis, purification) with a streamlined isothermal DNA amplification process. By using strand-displacement amplification of cDNA templates, the method eliminates the time-consuming transcription steps while maintaining the ability to amplify RNA samples, reducing total amplification time and producing more stable DNA amplificates.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Productivity

If exponential PCR amplification is used, then high amplification yields are achieved, but saturation occurs with excess input template quantities

Engineering Contradiction:
Improveamplification yieldVSAvoidamplification linearity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention segments the amplification into clonal pre-amplification (to achieve high yield from low input) and linear enrichment (to maintain reliability). The compartmentalized droplet system enables each template molecule to undergo independent clonal amplification, achieving high yields without saturation effects because each droplet processes individual templates separately. Subsequent linear enrichment maintains the proportional representation of different templates.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for accurate and unbiased amplification of nucleic acid sequences from minimal samples, enabling effective gene expression analysis and maintaining the representation of all types of nucleic acid molecules, even from as few as one cell, with high accuracy and precision.

Implementation Method 1

preparing a water in oil emulsion characterized in that the majority of water droplets comprises one or none member of said plurality of different nucleic acid molecules

Methodology Applied
Scientific EffectEmulsion: Emulsion

Data Source

PatentUS9650629B2Clonal pre-amplification in emulsion
Publication Date: 2017.05.16 ROCHE MOLECULAR SYSTEMS INC
  • US9650629B2 patent drawing
  • US9650629B2 patent drawing
  • US9650629B2 patent drawing

AI summary

Disclosed is a process for clonal pre-amplification of a nucleic acid involving the steps of (i) providing a plurality of different nucleic acid molecules (b) attaching adaptor sequences to the 3′ ends and 5′ ends of the nucleic acid molecules (c) preparing a water in oil emulsion wherein the majority of water droplets comprises one or none member of the plurality of different nucleic acid molecules (d) clonally amplifying the plurality of different nucleic acid molecules. In particular, the different nucleic acid molecules are mRNA molecules.